RNase L: Its biological roles and regulation

IUBMB Life

Volumn 58, Issue 9, 2006, Pages 508-514

  Liang, Shu Ling ^a   Quirk, David ^b   Zhou, Aimin ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Antivirus; Apoptosis; Interferon; Prostate cancer; RNase L

Indexed keywords

ALPHA INTERFERON; RIBONUCLEASE;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CYTOKINE RELEASE; NONHUMAN; PHOSPHORYLATION; RECEPTOR BINDING; REVIEW;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; CELL PROLIFERATION; DNA FRAGMENTATION; ENDORIBONUCLEASES; HUMANS; INTERFERONS; MALE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER;

EID: 33749150990     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540600838232     Document Type: Review

References (40)

1. Vilcek, J., and Sen, G. C. (1996) Interferons and other cytokines in B.N. Fields. In Fields Virology (Knipe, D. M., and Howley, P. M., eds) pp. 375-399. Lippincott-Raven, Philadelphia.
2. Hassel, B. A., Zhou, A., Sotomayor, C., Maran, A., and Silverman, R. H. (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12, 3297-3304.
3. Tanaka, N., Nakanishi, M., Kusakabe, Y., Goto, Y., Kitade, Y., and Nakamura, K. T. (2005) Structural basis for recognition of 2′,5′- linked oligoadenylates by human ribonuclease L. EMBO J. 23, 3929-3938.
4. Li, X. L., Blackford, J. A., Judge, C. S., Liu, M., Xiao, W., Kalvakolanu, D. V., and Hassel, B. A. (2000) RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J. Biol. Chem. 275, 8880-8888.
5. Khabar, K. S., Siddiqui, Y. M., Al-Zoghaibi, F., Al-Haj, L., Dhalla, M., Zhou, A., Dong, B., Whitmore, M., Paranjape, J., Al-Ahdal, M., Al-Mohanna, F. Williams, B. R., and Silverman, R. H. (2003) RNase L mediates transient control of interferon response through modulation of the double-stranded RNA dependent protein kinase PKR. J. Biol. Chem. 278, 20124-20132.
6. Bisbal, C., Silhol, M., Laubenthal, H., Kaluza, T., Carnac, G., Milligan, L., Le Roy, F., and Salehzada, T. (2000) The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol. Cell Biol. 20, 4959-4969.
7. Le Roy, F., Bisbal, C., Silhol, M., Martinand, C., Lebleu, B., and Salehzada, T. (2001) The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells. J. Biol. Chem. 276, 48473-48482.
8. Chandrasekaran, K., Mehrabian, Z., Li, X. L., and Hassel, B. (2004) RNase-L regulates the stability of mitochondrial DNA-encoded mRNAs in mouse embryo fibroblasts. Biochem Biophys. Res. Commun. 325, 18-23.
9. Li, X. L., Blackford, J. A., and Hassel, B. A. (1998) RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J. Virol. 72, 2752-2759.
10. Le Roy, F., Salehzada, T., Bisbal, C., Dougherty, J. P., and Peltz, S. W. (2005) A newly discovered function for RNase L in regulating translation termination. Nat. Struct. Mol. Biol. 12, 505-512.
11. Bettoun, D. J., Scafonas, A., Rutledge, S. J., Hodor, P., Chen, O., Gambone, C., Vogel, R., McElwee-Witmer, S., Bai, C., Freedman, L., and Schmidt, A. (2005) Interaction between the androgen receptor and RNase L mediates a cross-talk between the interferon and androgen signaling pathways. J. Biol. Chem. 280, 38898-38901.
12. Malathi, K., Paranjape, J. M., Bulanova, E., Shim, M., Guenther-Johnson, J. M., Faber, P. W., Eling, T. E., Williams, B. R., and Silverman, R. H. (2005) A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L. Proc. Natl. Acad. Sci. USA 102, 14533-14538.
13. Bisbal, C., Martinand, C., Silhol, M., Lebleu, B., and Salehzada, T. (1995) Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway. J. Biol. Chem. 270, 13308-13317.
14. Chase, B. I., Zhou, Y., Xiang, Y., Silverman, R. H., and Zhou, A. (2003) Proteasome-mediated degradation of RNase L in response to phorbol-12-myristate- 13-acetate (PMA) treatment of mouse L929 cells. J. Interferon Cytokine Res. 23, 565-573.
15. Sen, G. C., Lebleu, B., Brown, G. E., Kawakita, M., Slattery, E., and Lengyel, P. (1976) Interferon, double-stranded RNA and mRNA degradation. Nature 264, 370-373.
16. Defilippi, P., Huez, G., Verhaegen-Lawalle, M., De Clercq, E., Imai, J., Torrence, P., and Content, J. (1986) Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells. FEBS Lett. 198, 326-332.
17. Zhou, A., Paranjape, J. M., Hassel, B. A., Nie, H., Shah, S., Galinski, B., and Silverman, R. H. (1998) Impact of RNase L overexpression on viral and cellular growth and death. J. Interferon Cytokine Res. 18, 953-961.
18. Zhou, A., Paranjape, J., Brown, T. L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, B., Fairchild, R., Colmenares, C., and Silverman, R. H. (1997) Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
19. Silverman, R. H. (1996) 2-5A dependent Rnase L: a regulated endoribonuclease in the interferon system. In Ribonucleases: structure and function (D'alessio, G., and Riordan, J. F., eds) pp. 517-547, Academic Press, Inc., San Diego.
20. Rivas, C., Gil, J., Melkova, Z., Esteban, M., and Diaz-Guerra, M. (1998) Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 243, 406-414.
21. Beattie, E., Denzler, K. L., Tartaglia, J., Perkus, M. E., Paoletti, E., and Jacobs, B. L. (1995) Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69, 499-505.
22. Bisbal, C., Salehzada, T., Silhol, M., Martinand, C., Le Roy, F., and Lebleu, B. (2001) The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI). Methods Mol. Biol. 160, 183-198.
23. Diaz-Guerra, M., Rivas, C., and Esteban, M. (1997) Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236, 354-363.
24. Silverman, R. H. (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42, 1805-1812.
25. Li, G., Xiang, Y., Sabapathy, K., and Silverman, R. H. (2004) An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J. Biol. Chem. 279, 1123-1131.
26. Iordanov, M. S., Paranjape, J. M., Zhou, A., Wong, J., Williams, B. R., Meurs, E. F., Silverman, R. H., and Magun, B. E. (2000) Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell Biol. 20, 617-627.
27. Hovanessian, A.G., and Wood, J. N. (1980) Anticellular and antiviral effects of pppA(2′p5′A)n. Virology 101, 81-90.
28. Jacobsen, H., Krause, D., Friedman, R. M., and Silverman, R. H. (1983) Induction of ppp(A2′p)nA-dependent RNase in murine JLS-V9R cells during growth inhibition. Proc. Natl. Acad. Sci. USA 80, 4954-4958.
29. Krause, D., Panet, A., Arad, G., Dieffenbach, C. W., and Silverman, R. H. (1985) Independent regulation of ppp(A2′p)nA-dependent RNase in NIH 3T3, clone 1 cells by growth arrest and interferon treatment. J. Biol. Chem. 260, 9501-9507.
30. Squire, J., Zhou, A., Hassel, B. A., Nie, H., and Silverman, R. H. (1994) Localization of the interferon-induced, 2-5A-dependent RNase gene (RNS4) to human chromosome 1q25. Genomics 19, 174-175.
31. Tnani, M., and Bayard, B. A. (1998) Lack of 2′,5′- oligoadenylate-dependent RNase expression in the human hepatoma cell line HepG2. Biochim. Biophys. Acta 1402, 139-150.
32. Rokman, A., Ikonen, T., Seppala, E. H., Nupponen, N., Autio, V., Mononen, N., Bailey-Wilson, J., Trent, J., Carpten, J., Matikainen, M. P., Koivisto, P. A., Tammela, T. L., Kallioniemi, O. P., and Schleutker, J. (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am. J. Hum. Genet. 70, 1299-1304.
33. Casey, G., Neville, P. J., Plummer, S. J., Xiang, Y., Krumroy, L. M., Klein, E. A., Catalona, W. J., Nupponen, N., Carpten, J. D., Trent, J. M., Silverman, R. H., and Witte, J. S. (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat. Genet. 32, 581-583.
34. Rennert, H., Bercovich, D., Hubert, A., Abeliovich, D., Rozovsky, U., Bar-Shira, A., Soloviov, S., Schreiber, L., Matzkin, H., Rennert, G., Kadouri, L., Peretz, T., Yaron, Y., and Orr-Urtreger, A. (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am. J. Hum. Genet. 71, 981-984.
35. Zambrano, A., Kalantari, M., Simoneau, A., Jensen, J. L., and Villarreal, L. P. (2002) Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53, 263-276.
36. Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., Silverman, R. H., and Derisi, J. L. (2006) Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2, e25.
37. Malathi, K., Paranjape, J. M., Ganapathi, R., and Silverman, R. H. (2004) HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2′,5′-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 64, 9144-9151.
38. Demettre, E., Bastide, L., D'Haese, A., De Smet, K., De Meirleir, K., Tiev, K. P., Englebienne, P., and Lebleu, B. (2002) Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J. Biol. Chem. 277, 35746-35751.
39. Fremont, M., El Bakkouri, K., Vaeyens, F., Herst, C. V., DeMeirleir, K., and Englebienne, P. (2005) 2′,5′-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome. Exp. Mol. Pathol. 78, 239-246.
40. Silverman, R. H., Zhou, A., Auerbach, M. B., Kish, D., Gorbachev, A., and Fairchild, R. L. (2002) Skin allograft rejection is suppressed in mice lacking the antiviral enzyme, 2′,5′-oligoadenylate-dependent RNase L. Viral Immunol. 15, 77-83.